Blog
MD Anderson Scientist Awarded Research Grant
Can an epigenetic enzyme under the right conditions contribute to the growth of cancer cells? If so, what happens if the enzyme is removed? Can
May 23, 2018
No Comments
Can an epigenetic enzyme under the right conditions contribute to the growth of cancer cells? If so, what happens if the enzyme is removed? Can
National Cancer Survivors Day is Sunday, June 3, 2018 Show you are a NET survivor and celebrate life, acknowledge those living with this rare disease,
Having arrived seven weeks ago as the new Chief Development Officer, I have been so inspired by the team spirit of NETRF. From our dedicated
After you’ve been told you had food poisoning or were in menopause, but you had cancer….how do you learn to trust your doctor again? NET specialist Pamela Kunz, MD, talks about trust issues between doctors and patietnts.
Request for Applications Issued The Neuroendocrine Tumor Research Foundation (NETRF) has announced its latest Request for Applications (RFA) and invites innovative research applications in neuroendocrine
PRRT Patients Tell Their Stories Following the early 2018 FDA approval of the first Peptide Receptor Radionuclide Therapy (PRRT) using lutetium Lu-177 dotatate, many people are
NETRF announces the appointment of Susan Payson as Chief Development Officer. In this new position, Susan will work to expand NETRF’s base of support to
by Laran Hyder, NETRF Associate Director of Development and Outreach As a NET patient or caregiver, living with neuroendocrine cancer can be an isolating experience.
The first step in curing a disease is understanding it. Unfortunately, there is a lot we still don’t know about small-intestinal NETs (SI-NETs). That’s why
by Ronny Allan, NET Patient Activist Doctors and scientists are always looking for better ways to care for patients with cancer; they are looking for